<?xml version="1.0" encoding="UTF-8"?>
<xml>
  <records>
    <record>
      <ref-type name="Journal Article">17</ref-type>
      <contributors>
        <authors>
          <author>S. Ashok1</author>
          <author>M. Ejaz</author>
          <author>A. Manzoor</author>
          <author>M. F. Qadir2</author>
          <author>S. Nazir</author>
        </authors>
      </contributors>
      <titles>
        <title>ANTIBACTERIAL ACTIVITY OF TRIFLUOPERAZINE; IN VITRO SUSCEPTIBILITY OF MRSA STAPHYLOCOCCUS AUREUS, PSEUDOMONAS AERUGINOSA AND E. COLI, AND IN VIVO EVALUATION AGAINST METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS IN SURGICAL WOUND INFECTION MODEL</title>
        <secondary-title>Journal of Animal and Plant Sciences</secondary-title>
        <alt-title>JAPS</alt-title>
      </titles>
      <dates><year>2021</year><pub-dates><date>2021/08/07</date></pub-dates></dates>
      <volume>31</volume>
      <number>5</number>
      <pages>1287-1292</pages>
      <isbn>1018-7081</isbn>
      <electronic-resource-num>https://doi.org/10.36899/JAPS.2021.5.0329</electronic-resource-num>
      <abstract>&lt;p&gt;Management of surgical site infections (SSI) becomes very difficult due to Bacterial resistance. Current study was designed to determine&amp;nbsp;&lt;em&gt;in vitro&lt;/em&gt;&amp;nbsp;susceptibility and minimum inhibitory concentration of trifluoperazine against MRSA,&amp;nbsp;&lt;em&gt;Staphylococcus aureus&lt;/em&gt;,&amp;nbsp;&lt;em&gt;Pseudomonas aeruginosa&lt;/em&gt;&amp;nbsp;and&amp;nbsp;&lt;em&gt;E. coli&lt;/em&gt;, and determination of&amp;nbsp;&lt;em&gt;in vivo&lt;/em&gt;&amp;nbsp;antibacterial activity of trifluoperazine in induced surgical site infections by MRSA.&amp;nbsp;&lt;em&gt;In vitro&lt;/em&gt;&amp;nbsp;antibacterial activity of trifluoperazine was determined by disc diffusion susceptibility testing while determination of MIC by agar dilution technique.&amp;nbsp;&lt;em&gt;In vivo&lt;/em&gt;&amp;nbsp;antibacterial activity was observed by microbiological assessment of tissue harvested from the experimentally infected wound site and number of colony forming units per gram (cfu/gm) of tissue. The zones of growth inhibition of trifluoperazine were determined against&amp;nbsp;&lt;em&gt;MRSA, E. coli&lt;/em&gt;&amp;nbsp;and&amp;nbsp;&lt;em&gt;Pseudomonas aeruginosa.&amp;nbsp;&lt;/em&gt;At a disc potency of 25 &amp;micro;g no zone of inhibition was produced against any isolate. 50 &amp;micro;g produced 13 mm and 16 mm zone of inhibition against&amp;nbsp;&lt;em&gt;MRSA and Pseudomonas aeruginosa&amp;nbsp;&lt;/em&gt;respectively. Whereas, No zone against E. coli was observed at this concentration but, 12mm, 15mm and 18mm zones of inhibition were produced by 100&lt;em&gt;&amp;nbsp;&amp;micro;g,&amp;nbsp;&lt;/em&gt;150 &amp;micro;g&lt;em&gt;,&amp;nbsp;&lt;/em&gt;and 200&lt;em&gt;&amp;nbsp;&amp;micro;g&lt;/em&gt; per disc concentration of trifluoperazine respectively. The colony forming units/gram observed in trifluoperazine treated wounds were 2.93&amp;plusmn;0.02 x 10⁶ while in case of normal saline treated wounds the value was 6.68&amp;plusmn;0.07 x 10⁶. Results revealed the efficacy of trifluoperazine as a potentially therapeutic agent in the treatment of wound infection beds especially against MRSA.&lt;/p&gt;</abstract>
      <keywords><keyword>Trifluoperazine, Staphylococcus, Methicillin, Antibacterial, Wound Infection</keyword></keywords>
      <publisher>Pakistan Agricultural Scientists Forum</publisher>
      <urls><related-urls><url>https://thejaps.org.pk/AbstractView.aspx?mid=VS-20-0008</url></related-urls></urls>
    </record>
  </records>
</xml>
